{
    "title": "113_s2126",
    "content": "The Act may be cited as the \"Regenerative Medicine Promotion Act of 2014\". Congress finds that regenerative medicine has the potential to treat chronic diseases, reduce healthcare spending, and promote economic growth in the United States. Regenerative medicine products have successfully treated various health conditions and have the potential to provide cures for diseases like diabetes, heart disease, and cancer. A national strategy on regenerative medicine is crucial to ensure its potential in curing diseases, reducing healthcare costs, and boosting economic growth. The Department of Defense and Health and Human Services support regenerative medicine for treating battlefield injuries, promoting economic growth, and improving healthcare. Investing in regenerative medicine leads to economic growth, increased biotech employment, payroll boosts, and higher tax receipts. The Comptroller General of the United States will report on ongoing Federal programs and activities related to regenerative medicine within 90 days of this Act. Additionally, a Regenerative Medicine Coordinating Council will be established. The Regenerative Medicine Coordinating Council, established by the Secretary of Health and Human Services, includes members from various government agencies such as Commerce, Defense, Treasury, Veterans Affairs, and others appointed as needed. The Regenerative Medicine Coordinating Council, chaired by the Secretary of Health and Human Services, includes members appointed by the Secretary with expertise in various areas such as health insurers, regenerative medicine researchers, patient advocates, drug discovery, development, basic and translational research, medical devices, biomaterials, and clinical research. The Council's function is to prepare and update a national strategy to support research in regenerative medicine. The Regenerative Medicine Coordinating Council, chaired by the Secretary of Health and Human Services, aims to support research in regenerative medicine by developing national goals, priorities, funding sources, and consensus standards for regulatory approval of products. Recommendations on federal policies to support product development and marketing are also made. The Regenerative Medicine Coordinating Council, chaired by the Secretary of Health and Human Services, aims to support research in regenerative medicine by developing national goals, priorities, funding sources, and consensus standards for regulatory approval of products. The Council will also establish centers of excellence or consortia to advance regenerative medicine and adopt procedures for public input and submit annual reports to Congress, NIH, and FDA. The Regenerative Medicine Coordinating Council, chaired by the Secretary of Health and Human Services, aims to support research in regenerative medicine by providing recommendations on funding, regulatory policies, identifying products on the market and in development, research advancements, and assessing the economic impact of regenerative medicine. The Regenerative Medicine Coordinating Council, chaired by the Secretary of Health and Human Services, supports research in regenerative medicine by providing recommendations on funding, regulatory policies, and assessing the economic impact, including increases in tax revenues."
}